Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualizing Treatment for Asthma in Primary Care
NCT06272370Phase 4Completed
- Sponsor
- DARTNet Institute
- Start
- Feb 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in asthma, sponsored by DARTNet Institute. Started Feb 2024; status: completed.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06272370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06272370.